Belite Bio (NASDAQ:BLTE) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen lowered shares of Belite Bio (NASDAQ:BLTE – Free Report) from a hold rating to a sell rating in a research note issued to investors on Thursday. BLTE has been the topic of several other research reports. Cantor Fitzgerald restated an “overweight” rating on shares of Belite Bio in a research report on […]
Wall Street Zen lowered shares of Belite Bio (NASDAQ:BLTE – Free Report) from a hold rating to a sell rating in a research note issued to investors on Thursday. BLTE has been the topic of several other research reports. Cantor Fitzgerald restated an “overweight” rating on shares of Belite Bio in a research report on […]
